id
stringlengths
15
19
document_id
stringlengths
15
19
passages
list
entities
list
events
list
coreferences
list
relations
list
split_0_train_28200
split_0_train_28200
[ { "id": "split_0_train_28200_passage", "type": "progene_text", "text": [ "Identification of XDRP1 ; a Xenopus protein related to yeast Dsk2p binds to the N-terminus of cyclin A and inhibits its degradation ." ], "offsets": [ [ 0, 133 ] ] } ]
[ { "id": "split_0_train_45702_entity", "type": "progene_text", "text": [ "XDRP1" ], "offsets": [ [ 18, 23 ] ], "normalized": [] }, { "id": "split_0_train_45703_entity", "type": "progene_text", "text": [ "Dsk2p" ], "offsets": [ [ 61, 66 ] ], "normalized": [] }, { "id": "split_0_train_45704_entity", "type": "progene_text", "text": [ "cyclin A" ], "offsets": [ [ 94, 102 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28201
split_0_train_28201
[ { "id": "split_0_train_28201_passage", "type": "progene_text", "text": [ "Using the N - terminus of cyclin A1 in a two - hybrid screen as a bait , we identified a Xenopus protein , XDRP1 , that contains a ubiquitin - like domain in its N-terminus and shows significant homology in its C-terminal 50 residues to Saccharomyces cerevisiae Dsk2 and Schizosaccharomyces pombe dph1 ." ], "offsets": [ [ 0, 303 ] ] } ]
[ { "id": "split_0_train_45705_entity", "type": "progene_text", "text": [ "cyclin A1" ], "offsets": [ [ 26, 35 ] ], "normalized": [] }, { "id": "split_0_train_45706_entity", "type": "progene_text", "text": [ "XDRP1" ], "offsets": [ [ 107, 112 ] ], "normalized": [] }, { "id": "split_0_train_45707_entity", "type": "progene_text", "text": [ "ubiquitin" ], "offsets": [ [ 131, 140 ] ], "normalized": [] }, { "id": "split_0_train_45708_entity", "type": "progene_text", "text": [ "Dsk2" ], "offsets": [ [ 262, 266 ] ], "normalized": [] }, { "id": "split_0_train_45709_entity", "type": "progene_text", "text": [ "dph1" ], "offsets": [ [ 297, 301 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28202
split_0_train_28202
[ { "id": "split_0_train_28202_passage", "type": "progene_text", "text": [ "XDRP1 is a nuclear phosphoprotein in Xenopus cells , and its phosphorylation is mediated by cyclin A - dependent kinase ." ], "offsets": [ [ 0, 121 ] ] } ]
[ { "id": "split_0_train_45710_entity", "type": "progene_text", "text": [ "XDRP1" ], "offsets": [ [ 0, 5 ] ], "normalized": [] }, { "id": "split_0_train_45711_entity", "type": "progene_text", "text": [ "cyclin A" ], "offsets": [ [ 92, 100 ] ], "normalized": [] }, { "id": "split_0_train_45712_entity", "type": "progene_text", "text": [ "kinase" ], "offsets": [ [ 113, 119 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28203
split_0_train_28203
[ { "id": "split_0_train_28203_passage", "type": "progene_text", "text": [ "XDRP1 binds to both embryonic and somatic forms of cyclin A ( A1 and A2 ) in Xenopus cells , but not to B - type cyclins ." ], "offsets": [ [ 0, 122 ] ] } ]
[ { "id": "split_0_train_45713_entity", "type": "progene_text", "text": [ "XDRP1" ], "offsets": [ [ 0, 5 ] ], "normalized": [] }, { "id": "split_0_train_45714_entity", "type": "progene_text", "text": [ "cyclin A" ], "offsets": [ [ 51, 59 ] ], "normalized": [] }, { "id": "split_0_train_45715_entity", "type": "progene_text", "text": [ "B - type cyclins" ], "offsets": [ [ 104, 120 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28204
split_0_train_28204
[ { "id": "split_0_train_28204_passage", "type": "progene_text", "text": [ "The N - terminal ubiquitin - like domain of XDRP1 , but not the C - terminal Dsk2 - like domain , is required for interaction with cyclin A ." ], "offsets": [ [ 0, 141 ] ] } ]
[ { "id": "split_0_train_45716_entity", "type": "progene_text", "text": [ "ubiquitin" ], "offsets": [ [ 17, 26 ] ], "normalized": [] }, { "id": "split_0_train_45717_entity", "type": "progene_text", "text": [ "XDRP1" ], "offsets": [ [ 44, 49 ] ], "normalized": [] }, { "id": "split_0_train_45718_entity", "type": "progene_text", "text": [ "Dsk2" ], "offsets": [ [ 77, 81 ] ], "normalized": [] }, { "id": "split_0_train_45719_entity", "type": "progene_text", "text": [ "cyclin A" ], "offsets": [ [ 131, 139 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28205
split_0_train_28205
[ { "id": "split_0_train_28205_passage", "type": "progene_text", "text": [ "XDRP1 requires residues 130 - 160 of cyclin A1 for efficient binding , which do not include the destruction box of cyclin A ." ], "offsets": [ [ 0, 125 ] ] } ]
[ { "id": "split_0_train_45720_entity", "type": "progene_text", "text": [ "XDRP1" ], "offsets": [ [ 0, 5 ] ], "normalized": [] }, { "id": "split_0_train_45721_entity", "type": "progene_text", "text": [ "cyclin A1" ], "offsets": [ [ 37, 46 ] ], "normalized": [] }, { "id": "split_0_train_45722_entity", "type": "progene_text", "text": [ "cyclin A" ], "offsets": [ [ 115, 123 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28206
split_0_train_28206
[ { "id": "split_0_train_28206_passage", "type": "progene_text", "text": [ "The addition of bacterially expressed XDRP1 protein to frog egg extract inhibited the Ca(2+) - induced degradation of cyclin A , but not that of cyclin B ." ], "offsets": [ [ 0, 155 ] ] } ]
[ { "id": "split_0_train_45723_entity", "type": "progene_text", "text": [ "XDRP1" ], "offsets": [ [ 38, 43 ] ], "normalized": [] }, { "id": "split_0_train_45724_entity", "type": "progene_text", "text": [ "cyclin A" ], "offsets": [ [ 118, 126 ] ], "normalized": [] }, { "id": "split_0_train_45725_entity", "type": "progene_text", "text": [ "cyclin B" ], "offsets": [ [ 145, 153 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28207
split_0_train_28207
[ { "id": "split_0_train_28207_passage", "type": "progene_text", "text": [ "The injection of XDRP1 protein into fertilized Xenopus eggs blocked embryonic cell division ." ], "offsets": [ [ 0, 93 ] ] } ]
[ { "id": "split_0_train_45726_entity", "type": "progene_text", "text": [ "XDRP1" ], "offsets": [ [ 17, 22 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28208
split_0_train_28208
[ { "id": "split_0_train_28208_passage", "type": "progene_text", "text": [ "ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB ." ], "offsets": [ [ 0, 142 ] ] } ]
[ { "id": "split_0_train_45727_entity", "type": "progene_text", "text": [ "ERK MAP kinase" ], "offsets": [ [ 0, 14 ] ], "normalized": [] }, { "id": "split_0_train_45728_entity", "type": "progene_text", "text": [ "cytokine" ], "offsets": [ [ 21, 29 ] ], "normalized": [] }, { "id": "split_0_train_45729_entity", "type": "progene_text", "text": [ "AP-1" ], "offsets": [ [ 122, 126 ] ], "normalized": [] }, { "id": "split_0_train_45730_entity", "type": "progene_text", "text": [ "NF-kappaB" ], "offsets": [ [ 131, 140 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28209
split_0_train_28209
[ { "id": "split_0_train_28209_passage", "type": "progene_text", "text": [ "Human immunodeficiency virus type 1 ( HIV-1 ) can establish latent infection following provirus integration into the host genome ." ], "offsets": [ [ 0, 130 ] ] } ]
[]
[]
[]
[]
split_0_train_28210
split_0_train_28210
[ { "id": "split_0_train_28210_passage", "type": "progene_text", "text": [ "NF-kappaB plays a critical role in activation of HIV-1 gene expression by cytokines and other stimuli , but the signal transduction pathways that regulate the switch from latent to productive infection have not been defined ." ], "offsets": [ [ 0, 225 ] ] } ]
[ { "id": "split_0_train_45731_entity", "type": "progene_text", "text": [ "NF-kappaB" ], "offsets": [ [ 0, 9 ] ], "normalized": [] }, { "id": "split_0_train_45732_entity", "type": "progene_text", "text": [ "cytokines" ], "offsets": [ [ 74, 83 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28211
split_0_train_28211
[ { "id": "split_0_train_28211_passage", "type": "progene_text", "text": [ "Here , we show that ERK1 / ERK2 mitogen - activated protein kinase ( MAPK ) plays a central role in linking signals at the cell surface to activation of HIV-1 gene expression in latently infected cells ." ], "offsets": [ [ 0, 203 ] ] } ]
[ { "id": "split_0_train_45733_entity", "type": "progene_text", "text": [ "ERK1" ], "offsets": [ [ 20, 24 ] ], "normalized": [] }, { "id": "split_0_train_45734_entity", "type": "progene_text", "text": [ "ERK2" ], "offsets": [ [ 27, 31 ] ], "normalized": [] }, { "id": "split_0_train_45735_entity", "type": "progene_text", "text": [ "mitogen - activated protein kinase" ], "offsets": [ [ 32, 66 ] ], "normalized": [] }, { "id": "split_0_train_45736_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 69, 73 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28212
split_0_train_28212
[ { "id": "split_0_train_28212_passage", "type": "progene_text", "text": [ "MAPK was activated by cytokines and phorbol 12-myristate 13-acetate in latently infected U1 cells ." ], "offsets": [ [ 0, 99 ] ] } ]
[ { "id": "split_0_train_45737_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 0, 4 ] ], "normalized": [] }, { "id": "split_0_train_45738_entity", "type": "progene_text", "text": [ "cytokines" ], "offsets": [ [ 22, 31 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28213
split_0_train_28213
[ { "id": "split_0_train_28213_passage", "type": "progene_text", "text": [ "The induction of HIV-1 expression by these stimuli was inhibited by PD98059 and U0126 , which are specific inhibitors of MAPK activation ." ], "offsets": [ [ 0, 138 ] ] } ]
[ { "id": "split_0_train_45739_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 121, 125 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28214
split_0_train_28214
[ { "id": "split_0_train_28214_passage", "type": "progene_text", "text": [ "Studies using constitutively active MEK or Raf kinase mutants demonstrated that MAPK activates the HIV-1 long terminal repeat ( LTR ) through the NF-kappaB sites ." ], "offsets": [ [ 0, 163 ] ] } ]
[ { "id": "split_0_train_45740_entity", "type": "progene_text", "text": [ "MEK" ], "offsets": [ [ 36, 39 ] ], "normalized": [] }, { "id": "split_0_train_45741_entity", "type": "progene_text", "text": [ "Raf kinase" ], "offsets": [ [ 43, 53 ] ], "normalized": [] }, { "id": "split_0_train_45742_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 80, 84 ] ], "normalized": [] }, { "id": "split_0_train_45743_entity", "type": "progene_text", "text": [ "NF-kappaB" ], "offsets": [ [ 146, 155 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28215
split_0_train_28215
[ { "id": "split_0_train_28215_passage", "type": "progene_text", "text": [ "Most HIV-1 inducers activated NF-kappaB via a MAPK - independent pathway , indicating that activation of NF-kappaB is not sufficient to explain the activation of HIV-1 gene expression by MAPK ." ], "offsets": [ [ 0, 193 ] ] } ]
[ { "id": "split_0_train_45744_entity", "type": "progene_text", "text": [ "NF-kappaB" ], "offsets": [ [ 30, 39 ] ], "normalized": [] }, { "id": "split_0_train_45745_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 46, 50 ] ], "normalized": [] }, { "id": "split_0_train_45746_entity", "type": "progene_text", "text": [ "NF-kappaB" ], "offsets": [ [ 105, 114 ] ], "normalized": [] }, { "id": "split_0_train_45747_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 187, 191 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28216
split_0_train_28216
[ { "id": "split_0_train_28216_passage", "type": "progene_text", "text": [ "In contrast , all of the stimuli activated AP-1 via a MAPK - dependent pathway ." ], "offsets": [ [ 0, 80 ] ] } ]
[ { "id": "split_0_train_45748_entity", "type": "progene_text", "text": [ "AP-1" ], "offsets": [ [ 43, 47 ] ], "normalized": [] }, { "id": "split_0_train_45749_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 54, 58 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28217
split_0_train_28217
[ { "id": "split_0_train_28217_passage", "type": "progene_text", "text": [ "NF-kappaB and AP-1 components c-Fos and c-Jun were shown to physically associate by yeast two - hybrid assays and electrophoretic mobility shift assays ." ], "offsets": [ [ 0, 153 ] ] } ]
[ { "id": "split_0_train_45750_entity", "type": "progene_text", "text": [ "NF-kappaB" ], "offsets": [ [ 0, 9 ] ], "normalized": [] }, { "id": "split_0_train_45751_entity", "type": "progene_text", "text": [ "AP-1" ], "offsets": [ [ 14, 18 ] ], "normalized": [] }, { "id": "split_0_train_45752_entity", "type": "progene_text", "text": [ "c-Fos" ], "offsets": [ [ 30, 35 ] ], "normalized": [] }, { "id": "split_0_train_45753_entity", "type": "progene_text", "text": [ "c-Jun" ], "offsets": [ [ 40, 45 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28218
split_0_train_28218
[ { "id": "split_0_train_28218_passage", "type": "progene_text", "text": [ "Coexpression of NF-kappaB and c-Fos or c-Jun synergistically transactivated the HIV-1 LTR through the NF-kappaB sites ." ], "offsets": [ [ 0, 119 ] ] } ]
[ { "id": "split_0_train_45754_entity", "type": "progene_text", "text": [ "NF-kappaB" ], "offsets": [ [ 16, 25 ] ], "normalized": [] }, { "id": "split_0_train_45755_entity", "type": "progene_text", "text": [ "c-Fos" ], "offsets": [ [ 30, 35 ] ], "normalized": [] }, { "id": "split_0_train_45756_entity", "type": "progene_text", "text": [ "c-Jun" ], "offsets": [ [ 39, 44 ] ], "normalized": [] }, { "id": "split_0_train_45757_entity", "type": "progene_text", "text": [ "NF-kappaB" ], "offsets": [ [ 102, 111 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28219
split_0_train_28219
[ { "id": "split_0_train_28219_passage", "type": "progene_text", "text": [ "These studies suggest that MAPK acts by stimulating AP-1 and a subsequent physical and functional interaction of AP-1 with NF-kappaB , resulting in a complex that synergistically transactivates the HIV-1 LTR ." ], "offsets": [ [ 0, 209 ] ] } ]
[ { "id": "split_0_train_45758_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 27, 31 ] ], "normalized": [] }, { "id": "split_0_train_45759_entity", "type": "progene_text", "text": [ "AP-1" ], "offsets": [ [ 52, 56 ] ], "normalized": [] }, { "id": "split_0_train_45760_entity", "type": "progene_text", "text": [ "AP-1" ], "offsets": [ [ 113, 117 ] ], "normalized": [] }, { "id": "split_0_train_45761_entity", "type": "progene_text", "text": [ "NF-kappaB" ], "offsets": [ [ 123, 132 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28220
split_0_train_28220
[ { "id": "split_0_train_28220_passage", "type": "progene_text", "text": [ "These results define a mechanism for signal - dependent activation of HIV-1 replication in latently infected cells and suggest potential therapeutic strategies for unmasking latent reservoirs of HIV-1 ." ], "offsets": [ [ 0, 202 ] ] } ]
[]
[]
[]
[]
split_0_train_28221
split_0_train_28221
[ { "id": "split_0_train_28221_passage", "type": "progene_text", "text": [ "Ras - GTPase activating protein inhibition specifically induces apoptosis of tumour cells ." ], "offsets": [ [ 0, 91 ] ] } ]
[ { "id": "split_0_train_45762_entity", "type": "progene_text", "text": [ "Ras - GTPase activating protein" ], "offsets": [ [ 0, 31 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28222
split_0_train_28222
[ { "id": "split_0_train_28222_passage", "type": "progene_text", "text": [ "Oncogenes and tumour suppressor genes control the balance between apoptotic death and anti - apoptotic survival signals determining whether a cell proliferates or dies ." ], "offsets": [ [ 0, 169 ] ] } ]
[]
[]
[]
[]
split_0_train_28223
split_0_train_28223
[ { "id": "split_0_train_28223_passage", "type": "progene_text", "text": [ "Through which effectors might oncoproteins generate sensitivity to apoptosis remains to be determined ." ], "offsets": [ [ 0, 103 ] ] } ]
[]
[]
[]
[]
split_0_train_28224
split_0_train_28224
[ { "id": "split_0_train_28224_passage", "type": "progene_text", "text": [ "Ras GTPase activating protein ( Ras-GAP ) is a key element in the Ras signalling pathway , being both a negative regulator and possibly an effector of Ras ." ], "offsets": [ [ 0, 156 ] ] } ]
[ { "id": "split_0_train_45763_entity", "type": "progene_text", "text": [ "Ras GTPase activating protein" ], "offsets": [ [ 0, 29 ] ], "normalized": [] }, { "id": "split_0_train_45764_entity", "type": "progene_text", "text": [ "Ras-GAP" ], "offsets": [ [ 32, 39 ] ], "normalized": [] }, { "id": "split_0_train_45765_entity", "type": "progene_text", "text": [ "Ras" ], "offsets": [ [ 66, 69 ] ], "normalized": [] }, { "id": "split_0_train_45766_entity", "type": "progene_text", "text": [ "Ras" ], "offsets": [ [ 151, 154 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28225
split_0_train_28225
[ { "id": "split_0_train_28225_passage", "type": "progene_text", "text": [ "Ras-GAP acts as a regulator of transcription , and possibly connects Ras to stress - activated protein kinases ." ], "offsets": [ [ 0, 112 ] ] } ]
[ { "id": "split_0_train_45767_entity", "type": "progene_text", "text": [ "Ras-GAP" ], "offsets": [ [ 0, 7 ] ], "normalized": [] }, { "id": "split_0_train_45768_entity", "type": "progene_text", "text": [ "Ras" ], "offsets": [ [ 69, 72 ] ], "normalized": [] }, { "id": "split_0_train_45769_entity", "type": "progene_text", "text": [ "stress - activated protein kinases" ], "offsets": [ [ 76, 110 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28226
split_0_train_28226
[ { "id": "split_0_train_28226_passage", "type": "progene_text", "text": [ "A role for Ras-GAP in cell survival has been suspected from the study of knock - out mouse embryos ." ], "offsets": [ [ 0, 100 ] ] } ]
[ { "id": "split_0_train_45770_entity", "type": "progene_text", "text": [ "Ras-GAP" ], "offsets": [ [ 11, 18 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28227
split_0_train_28227
[ { "id": "split_0_train_28227_passage", "type": "progene_text", "text": [ "In search for selective killing of tumour cells , we asked whether Ras - GAP inhibition by other means would lead to apoptosis in established cell lines ." ], "offsets": [ [ 0, 154 ] ] } ]
[ { "id": "split_0_train_45771_entity", "type": "progene_text", "text": [ "Ras - GAP" ], "offsets": [ [ 67, 76 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28228
split_0_train_28228
[ { "id": "split_0_train_28228_passage", "type": "progene_text", "text": [ "We injected a monoclonal antibody directed against the SH3 domain of Ras-GAP ( mAb200 ) that has been shown to block Ras-GAP downstream signalling into various human normal and tumour cell lines ." ], "offsets": [ [ 0, 196 ] ] } ]
[ { "id": "split_0_train_45772_entity", "type": "progene_text", "text": [ "Ras-GAP" ], "offsets": [ [ 69, 76 ] ], "normalized": [] }, { "id": "split_0_train_45773_entity", "type": "progene_text", "text": [ "Ras-GAP" ], "offsets": [ [ 117, 124 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28229
split_0_train_28229
[ { "id": "split_0_train_28229_passage", "type": "progene_text", "text": [ "We show that inhibition of Ras-GAP induces apoptosis specifically in tumour , but not in normal cells , therefore pointing at a specific role for Ras-GAP in tumour cell survival ." ], "offsets": [ [ 0, 179 ] ] } ]
[ { "id": "split_0_train_45774_entity", "type": "progene_text", "text": [ "Ras-GAP" ], "offsets": [ [ 27, 34 ] ], "normalized": [] }, { "id": "split_0_train_45775_entity", "type": "progene_text", "text": [ "Ras-GAP" ], "offsets": [ [ 146, 153 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28230
split_0_train_28230
[ { "id": "split_0_train_28230_passage", "type": "progene_text", "text": [ "MAb200 - induced apoptosis is largely prevented by coinjection of activated RhoA or Cdc42 proteins , by injection of a constitutively activated mutant of phosphoinositide 3-OH kinase ( PI3-K ) , but not by injection of v-Raf ." ], "offsets": [ [ 0, 226 ] ] } ]
[ { "id": "split_0_train_45776_entity", "type": "progene_text", "text": [ "RhoA" ], "offsets": [ [ 76, 80 ] ], "normalized": [] }, { "id": "split_0_train_45777_entity", "type": "progene_text", "text": [ "Cdc42" ], "offsets": [ [ 84, 89 ] ], "normalized": [] }, { "id": "split_0_train_45778_entity", "type": "progene_text", "text": [ "phosphoinositide 3-OH kinase" ], "offsets": [ [ 154, 182 ] ], "normalized": [] }, { "id": "split_0_train_45779_entity", "type": "progene_text", "text": [ "PI3-K" ], "offsets": [ [ 185, 190 ] ], "normalized": [] }, { "id": "split_0_train_45780_entity", "type": "progene_text", "text": [ "v-Raf" ], "offsets": [ [ 219, 224 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28231
split_0_train_28231
[ { "id": "split_0_train_28231_passage", "type": "progene_text", "text": [ "These results show that targeting of Ras-GAP could represent a novel anticancer approach ." ], "offsets": [ [ 0, 90 ] ] } ]
[ { "id": "split_0_train_45781_entity", "type": "progene_text", "text": [ "Ras-GAP" ], "offsets": [ [ 37, 44 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28232
split_0_train_28232
[ { "id": "split_0_train_28232_passage", "type": "progene_text", "text": [ "Mutations in the C , D , and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates ." ], "offsets": [ [ 0, 134 ] ] } ]
[]
[]
[]
[]
split_0_train_28233
split_0_train_28233
[ { "id": "split_0_train_28233_passage", "type": "progene_text", "text": [ "Human parainfluenza virus type 3 ( HPIV3 ) is a single - stranded negative - sense RNA virus belonging to the Respirovirus genus of the Paramyxoviridae family in the order Mononegavirales ." ], "offsets": [ [ 0, 189 ] ] } ]
[]
[]
[]
[]
split_0_train_28234
split_0_train_28234
[ { "id": "split_0_train_28234_passage", "type": "progene_text", "text": [ "The P gene encodes at least four proteins , including the C protein , which is expressed from an open reading frame ( ORF ) that overlaps the P ORF , and the D protein , which is encoded when the P ORF is fused to the D ORF by transcriptional editing ." ], "offsets": [ [ 0, 252 ] ] } ]
[]
[]
[]
[]
split_0_train_28235
split_0_train_28235
[ { "id": "split_0_train_28235_passage", "type": "progene_text", "text": [ "The P mRNA also contains a third ORF for the V protein , although it is unclear how or whether this ORF is accessed ." ], "offsets": [ [ 0, 117 ] ] } ]
[]
[]
[]
[]
split_0_train_28236
split_0_train_28236
[ { "id": "split_0_train_28236_passage", "type": "progene_text", "text": [ "We have used recombinant DNA technology to recover five mutant viruses that either interrupt or alter the C , D , and V ORFs ." ], "offsets": [ [ 0, 126 ] ] } ]
[]
[]
[]
[]
split_0_train_28237
split_0_train_28237
[ { "id": "split_0_train_28237_passage", "type": "progene_text", "text": [ "In one mutant virus , rC-KO , expression of the C protein was abrogated by changing the start codon from methionine to threonine and introducing two stop codons at amino acid positions 7 and 26 of the C ORF ." ], "offsets": [ [ 0, 208 ] ] } ]
[]
[]
[]
[]
split_0_train_28238
split_0_train_28238
[ { "id": "split_0_train_28238_passage", "type": "progene_text", "text": [ "In a second mutant virus , rF164S , a point mutation was introduced into the C ORF changing amino acid position 164 from phenylalanine ( F ) to serine ( S ) , which corresponds to the F170S mutation described in the C protein of Sendai virus ( Itoh et al. , J. Gen. Virol. 78 , 3207 - 3215 ) ." ], "offsets": [ [ 0, 293 ] ] } ]
[]
[]
[]
[]
split_0_train_28239
split_0_train_28239
[ { "id": "split_0_train_28239_passage", "type": "progene_text", "text": [ "rC-KO was significantly attenuated in vitro and in vivo ( rodents and primates ) , whereas rF164S was attenuated only in vivo ." ], "offsets": [ [ 0, 127 ] ] } ]
[]
[]
[]
[]
split_0_train_28240
split_0_train_28240
[ { "id": "split_0_train_28240_passage", "type": "progene_text", "text": [ "Interestingly , the rF164S mutant was more attenuated in the upper than in the lower respiratory tract of hamsters and monkeys ." ], "offsets": [ [ 0, 128 ] ] } ]
[]
[]
[]
[]
split_0_train_28241
split_0_train_28241
[ { "id": "split_0_train_28241_passage", "type": "progene_text", "text": [ "This pattern is the converse of that seen with temperature - sensitive attenuating mutations , and thus inclusion of this novel mutation in a recombinant live - attenuated vaccine candidate might prove useful in reducing residual virulence in the upper respiratory tract ." ], "offsets": [ [ 0, 272 ] ] } ]
[]
[]
[]
[]
split_0_train_28242
split_0_train_28242
[ { "id": "split_0_train_28242_passage", "type": "progene_text", "text": [ "Both rC-KO and rF164S conferred protection against challenge with wild - type HPIV3 ." ], "offsets": [ [ 0, 85 ] ] } ]
[]
[]
[]
[]
split_0_train_28243
split_0_train_28243
[ { "id": "split_0_train_28243_passage", "type": "progene_text", "text": [ "In three other viruses , the D and V ORFs were interrupted singly or in combination ." ], "offsets": [ [ 0, 85 ] ] } ]
[]
[]
[]
[]
split_0_train_28244
split_0_train_28244
[ { "id": "split_0_train_28244_passage", "type": "progene_text", "text": [ "Although interruption of the D and V ORFs individually did not affect virus replication in vitro or in vivo , interruption of both together attenuated replication in vivo ." ], "offsets": [ [ 0, 172 ] ] } ]
[]
[]
[]
[]
split_0_train_28245
split_0_train_28245
[ { "id": "split_0_train_28245_passage", "type": "progene_text", "text": [ "These results indicate that the C , D , and V proteins of HPIV3 each has a role in virus replication in vitro , in vivo , or both , and define mutations that might be useful for the development of a vaccine against HPIV3 ." ], "offsets": [ [ 0, 222 ] ] } ]
[]
[]
[]
[]
split_0_train_28246
split_0_train_28246
[ { "id": "split_0_train_28246_passage", "type": "progene_text", "text": [ "A clinical trial of the ReSound IC4 hearing device ." ], "offsets": [ [ 0, 52 ] ] } ]
[]
[]
[]
[]
split_0_train_28247
split_0_train_28247
[ { "id": "split_0_train_28247_passage", "type": "progene_text", "text": [ "A manufacturer - sponsored clinical trial was conducted of ReSound Corporation 's IC4 hearing device ( HD ) , an in-the-ear application of their two - channel , fast - acting , wide - dynamic range compression sound processor ." ], "offsets": [ [ 0, 227 ] ] } ]
[]
[]
[]
[]
split_0_train_28248
split_0_train_28248
[ { "id": "split_0_train_28248_passage", "type": "progene_text", "text": [ "This study was a follow - up to an earlier clinical trial of ReSound 's behind-the-ear version of the same sound processor , the BT2 Personal Hearing System ( Walden , B. E. , Surr , R. K. , Cord , M. T. , & Pavlovic , C. V. ( 1998 ) . A clinical trial of the ReSound BT2 Personal Hearing System. American Journal of Audiology , 7 , 85-100 ) ." ], "offsets": [ [ 0, 343 ] ] } ]
[]
[]
[]
[]
split_0_train_28249
split_0_train_28249
[ { "id": "split_0_train_28249_passage", "type": "progene_text", "text": [ "Forty adult males with gradually sloping , moderate sensorineural hearing losses participated ." ], "offsets": [ [ 0, 95 ] ] } ]
[]
[]
[]
[]
split_0_train_28250
split_0_train_28250
[ { "id": "split_0_train_28250_passage", "type": "progene_text", "text": [ "All were experienced hearing aid users who wore linear Class D instruments with input compression limiting at the time of their enrollment in this study ." ], "offsets": [ [ 0, 154 ] ] } ]
[]
[]
[]
[]
split_0_train_28251
split_0_train_28251
[ { "id": "split_0_train_28251_passage", "type": "progene_text", "text": [ "The Connected Speech Test , presented at several presentation levels and under various conditions of signal degradation , and the scales and subscales of the Profile of Hearing Aid Benefit were used to evaluate hearing aid performance and benefit under four relatively independent prototype listening situations ( Walden , B. E. , Demorest , M. E. , & Hepler , E. L. ( 1984 ) . Self - report approach to assessing benefit derived from amplification. Journal of Speech and Hearing Research , 27 , 49-56 ) ." ], "offsets": [ [ 0, 505 ] ] } ]
[]
[]
[]
[]
split_0_train_28252
split_0_train_28252
[ { "id": "split_0_train_28252_passage", "type": "progene_text", "text": [ "Aided performance with the IC4 HD was compared with (a) unaided performance , (b) performance of persons with normal hearing , and (c) performance with linear amplification ." ], "offsets": [ [ 0, 174 ] ] } ]
[]
[]
[]
[]
split_0_train_28253
split_0_train_28253
[ { "id": "split_0_train_28253_passage", "type": "progene_text", "text": [ "Participants with hearing loss obtained significant benefit from the IC4 HD , although IC4 - aided performance remained well below that of unaided performance of persons with normal hearing , especially on laboratory measures of speech recognition ." ], "offsets": [ [ 0, 249 ] ] } ]
[]
[]
[]
[]
split_0_train_28254
split_0_train_28254
[ { "id": "split_0_train_28254_passage", "type": "progene_text", "text": [ "Furthermore , small mean performance advantages were observed for the IC4 HD compared to linear hearing aids , although there was substantial variability across participants ." ], "offsets": [ [ 0, 175 ] ] } ]
[]
[]
[]
[]
split_0_train_28255
split_0_train_28255
[ { "id": "split_0_train_28255_passage", "type": "progene_text", "text": [ "Finally , when given a choice to either purchase the IC4 HD at a discount from the manufacturer or continue using their own government - issued linear hearing aids , the majority of the participants chose to purchase the IC4 HD ." ], "offsets": [ [ 0, 229 ] ] } ]
[]
[]
[]
[]
split_0_train_28256
split_0_train_28256
[ { "id": "split_0_train_28256_passage", "type": "progene_text", "text": [ "Defective and wild - type human T-cell leukemia virus type I proviruses : characterization of gene products and trans - interactions between proviruses ." ], "offsets": [ [ 0, 153 ] ] } ]
[]
[]
[]
[]
split_0_train_28257
split_0_train_28257
[ { "id": "split_0_train_28257_passage", "type": "progene_text", "text": [ "Defective provirus genomes of human T-cell leukemia virus type I are frequently detected in lymphocytes from infected individuals and in infected cell lines ." ], "offsets": [ [ 0, 158 ] ] } ]
[]
[]
[]
[]
split_0_train_28258
split_0_train_28258
[ { "id": "split_0_train_28258_passage", "type": "progene_text", "text": [ "One type of defective provirus contains internal deletions spanning gag , pol , and env genes but retains portions of open reading frames for trans - regulatory proteins ." ], "offsets": [ [ 0, 171 ] ] } ]
[ { "id": "split_0_train_45782_entity", "type": "progene_text", "text": [ "gag" ], "offsets": [ [ 68, 71 ] ], "normalized": [] }, { "id": "split_0_train_45783_entity", "type": "progene_text", "text": [ "pol" ], "offsets": [ [ 74, 77 ] ], "normalized": [] }, { "id": "split_0_train_45784_entity", "type": "progene_text", "text": [ "env" ], "offsets": [ [ 84, 87 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28259
split_0_train_28259
[ { "id": "split_0_train_28259_passage", "type": "progene_text", "text": [ "The deleted proviruses could potentially contribute to viral pathology by producing novel gene products that directly affect cell metabolism or that modulate expression of resident , wild - type proviruses ." ], "offsets": [ [ 0, 207 ] ] } ]
[]
[]
[]
[]
split_0_train_28260
split_0_train_28260
[ { "id": "split_0_train_28260_passage", "type": "progene_text", "text": [ "Virus gene products and the control of their expression were examined in cells transfected with defined molecular clones of wild - type and defective proviruses ." ], "offsets": [ [ 0, 162 ] ] } ]
[]
[]
[]
[]
split_0_train_28261
split_0_train_28261
[ { "id": "split_0_train_28261_passage", "type": "progene_text", "text": [ "Internally deleted provirus clones , which are unable to produce functional Tax and Rex proteins , were transcriptionally inactive in transfected cells ." ], "offsets": [ [ 0, 153 ] ] } ]
[ { "id": "split_0_train_45785_entity", "type": "progene_text", "text": [ "Tax" ], "offsets": [ [ 76, 79 ] ], "normalized": [] }, { "id": "split_0_train_45786_entity", "type": "progene_text", "text": [ "Rex" ], "offsets": [ [ 84, 87 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28262
split_0_train_28262
[ { "id": "split_0_train_28262_passage", "type": "progene_text", "text": [ "Ectopic expression of p40Tax activated transcription of the deleted provirus , resulting in the accumulation of a two - exon mRNA that yields a truncated form of Rex ( p21Rex ) ." ], "offsets": [ [ 0, 178 ] ] } ]
[ { "id": "split_0_train_45787_entity", "type": "progene_text", "text": [ "p40Tax" ], "offsets": [ [ 22, 28 ] ], "normalized": [] }, { "id": "split_0_train_45788_entity", "type": "progene_text", "text": [ "Rex" ], "offsets": [ [ 162, 165 ] ], "normalized": [] }, { "id": "split_0_train_45789_entity", "type": "progene_text", "text": [ "p21Rex" ], "offsets": [ [ 168, 174 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28263
split_0_train_28263
[ { "id": "split_0_train_28263_passage", "type": "progene_text", "text": [ "Although this two - exon mRNA also has a potential initiation codon in the tax frame , a truncated form of Tax was not detected by immunoblotting or in transactivation assays ." ], "offsets": [ [ 0, 176 ] ] } ]
[ { "id": "split_0_train_45790_entity", "type": "progene_text", "text": [ "Tax" ], "offsets": [ [ 107, 110 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28264
split_0_train_28264
[ { "id": "split_0_train_28264_passage", "type": "progene_text", "text": [ "When complemented with p40Tax and p27Rex , cells transfected with deleted proviruses accumulated an unspliced mRNA that could potentially encode gag - pX fusion proteins ." ], "offsets": [ [ 0, 171 ] ] } ]
[ { "id": "split_0_train_45791_entity", "type": "progene_text", "text": [ "p40Tax" ], "offsets": [ [ 23, 29 ] ], "normalized": [] }, { "id": "split_0_train_45792_entity", "type": "progene_text", "text": [ "p27Rex" ], "offsets": [ [ 34, 40 ] ], "normalized": [] }, { "id": "split_0_train_45793_entity", "type": "progene_text", "text": [ "gag" ], "offsets": [ [ 145, 148 ] ], "normalized": [] }, { "id": "split_0_train_45794_entity", "type": "progene_text", "text": [ "pX" ], "offsets": [ [ 151, 153 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28265
split_0_train_28265
[ { "id": "split_0_train_28265_passage", "type": "progene_text", "text": [ "Although expression of deleted proviruses was dependent on trans - acting factors produced from intact proviruses , gene products from defective proviruses did not significantly affect expression of a cotransfected , full - length provirus ." ], "offsets": [ [ 0, 241 ] ] } ]
[]
[]
[]
[]
split_0_train_28266
split_0_train_28266
[ { "id": "split_0_train_28266_passage", "type": "progene_text", "text": [ "Zinc finger of replication protein A , a non - DNA binding element , regulates its DNA binding activity through redox ." ], "offsets": [ [ 0, 119 ] ] } ]
[ { "id": "split_0_train_45795_entity", "type": "progene_text", "text": [ "replication protein A" ], "offsets": [ [ 15, 36 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28267
split_0_train_28267
[ { "id": "split_0_train_28267_passage", "type": "progene_text", "text": [ "Eukaryotic replication protein A ( RPA ) is a single - stranded DNA - binding protein with multiple functions in DNA replication , repair , and genetic recombination ." ], "offsets": [ [ 0, 167 ] ] } ]
[ { "id": "split_0_train_45796_entity", "type": "progene_text", "text": [ "replication protein A" ], "offsets": [ [ 11, 32 ] ], "normalized": [] }, { "id": "split_0_train_45797_entity", "type": "progene_text", "text": [ "RPA" ], "offsets": [ [ 35, 38 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28268
split_0_train_28268
[ { "id": "split_0_train_28268_passage", "type": "progene_text", "text": [ "RPA contains an evolutionarily conserved 4 - cysteine - type zinc finger motif ( X(3)CX(2-4)CX(12-15)CX(2) C ) that has a potential role in regulation of DNA replication and repair ( Dong , J. , Park , J-S. , and Lee , S-H. ( 1999 ) Biochem. J. 337 , 311 - 317 and Lin , Y. - L. , Shivji , M. K. K. , Chen , C. , Kolodner , R. , Wood , R. D. , and Dutta , A. ( 1998 ) J. Biol. Chem. 273 , 1453 - 1461 ) , even though the zinc finger itself is not essential for its DNA binding activity ( Kim , D. K. , Stigger , E. , and Lee , S. - H. ( 1996 ) J. Biol. Chem. 271 , 15124 - 15129 ) ." ], "offsets": [ [ 0, 582 ] ] } ]
[ { "id": "split_0_train_45798_entity", "type": "progene_text", "text": [ "RPA" ], "offsets": [ [ 0, 3 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28269
split_0_train_28269
[ { "id": "split_0_train_28269_passage", "type": "progene_text", "text": [ "Here , we show that RPA single - stranded DNA ( ssDNA ) binding activity is regulated by reduction - oxidation ( redox ) through its zinc finger domain ." ], "offsets": [ [ 0, 153 ] ] } ]
[ { "id": "split_0_train_45799_entity", "type": "progene_text", "text": [ "RPA" ], "offsets": [ [ 20, 23 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28270
split_0_train_28270
[ { "id": "split_0_train_28270_passage", "type": "progene_text", "text": [ "RPA - ssDNA interaction was stimulated 10 - fold by the reducing agent , dithiothreitol ( DTT ) , whereas treatment of RPA with oxidizing agent , diazene dicarboxylic acid bis[N,N-dimethylamide ] ( diamide ) , significantly reduced this interaction ." ], "offsets": [ [ 0, 250 ] ] } ]
[ { "id": "split_0_train_45800_entity", "type": "progene_text", "text": [ "RPA" ], "offsets": [ [ 0, 3 ] ], "normalized": [] }, { "id": "split_0_train_45801_entity", "type": "progene_text", "text": [ "RPA" ], "offsets": [ [ 119, 122 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28271
split_0_train_28271
[ { "id": "split_0_train_28271_passage", "type": "progene_text", "text": [ "The effect of diamide was reversed by the addition of excess DTT , suggesting that RPA ssDNA binding activity is regulated by redox ." ], "offsets": [ [ 0, 133 ] ] } ]
[ { "id": "split_0_train_45802_entity", "type": "progene_text", "text": [ "RPA" ], "offsets": [ [ 83, 86 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28272
split_0_train_28272
[ { "id": "split_0_train_28272_passage", "type": "progene_text", "text": [ "Redox regulation of RPA - ssDNA interaction was more effective in the presence of 0.2 M NaCl or higher ." ], "offsets": [ [ 0, 104 ] ] } ]
[ { "id": "split_0_train_45803_entity", "type": "progene_text", "text": [ "RPA" ], "offsets": [ [ 20, 23 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28273
split_0_train_28273
[ { "id": "split_0_train_28273_passage", "type": "progene_text", "text": [ "Cellular redox factor , thioredoxin , was able to replace DTT in stimulation of RPA DNA binding activity , suggesting that redox protein may be involved in RPA modulation in vivo ." ], "offsets": [ [ 0, 180 ] ] } ]
[ { "id": "split_0_train_45804_entity", "type": "progene_text", "text": [ "RPA" ], "offsets": [ [ 80, 83 ] ], "normalized": [] }, { "id": "split_0_train_45805_entity", "type": "progene_text", "text": [ "RPA" ], "offsets": [ [ 156, 159 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28274
split_0_train_28274
[ { "id": "split_0_train_28274_passage", "type": "progene_text", "text": [ "In contrast to wild - type RPA , zinc finger mutant ( cysteine to alanine mutation at amino acid 486 ) did not require DTT for its ssDNA binding activity and is not affected by redox ." ], "offsets": [ [ 0, 184 ] ] } ]
[ { "id": "split_0_train_45806_entity", "type": "progene_text", "text": [ "RPA" ], "offsets": [ [ 27, 30 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28275
split_0_train_28275
[ { "id": "split_0_train_28275_passage", "type": "progene_text", "text": [ "Together , these results suggest a novel function for a putative zinc finger in the regulation of RPA DNA binding activity through cellular redox ." ], "offsets": [ [ 0, 147 ] ] } ]
[ { "id": "split_0_train_45807_entity", "type": "progene_text", "text": [ "RPA" ], "offsets": [ [ 98, 101 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28276
split_0_train_28276
[ { "id": "split_0_train_28276_passage", "type": "progene_text", "text": [ "Complex formation with focal adhesion kinase :" ], "offsets": [ [ 0, 46 ] ] } ]
[ { "id": "split_0_train_45808_entity", "type": "progene_text", "text": [ "focal adhesion kinase" ], "offsets": [ [ 23, 44 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28277
split_0_train_28277
[ { "id": "split_0_train_28277_passage", "type": "progene_text", "text": [ "A mechanism to regulate activity and subcellular localization of Src kinases ." ], "offsets": [ [ 0, 78 ] ] } ]
[ { "id": "split_0_train_45809_entity", "type": "progene_text", "text": [ "Src" ], "offsets": [ [ 65, 68 ] ], "normalized": [] }, { "id": "split_0_train_45810_entity", "type": "progene_text", "text": [ "kinases" ], "offsets": [ [ 69, 76 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28278
split_0_train_28278
[ { "id": "split_0_train_28278_passage", "type": "progene_text", "text": [ "Tyrosine phosphorylation of focal adhesion kinase ( FAK ) creates a high - affinity binding site for the src homology 2 domain of the Src family of tyrosine kinases ." ], "offsets": [ [ 0, 166 ] ] } ]
[ { "id": "split_0_train_45811_entity", "type": "progene_text", "text": [ "focal adhesion kinase" ], "offsets": [ [ 28, 49 ] ], "normalized": [] }, { "id": "split_0_train_45812_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 52, 55 ] ], "normalized": [] }, { "id": "split_0_train_45813_entity", "type": "progene_text", "text": [ "src" ], "offsets": [ [ 105, 108 ] ], "normalized": [] }, { "id": "split_0_train_45814_entity", "type": "progene_text", "text": [ "Src family of tyrosine kinases" ], "offsets": [ [ 134, 164 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28279
split_0_train_28279
[ { "id": "split_0_train_28279_passage", "type": "progene_text", "text": [ "Assembly of a complex between FAK and Src kinases may serve to regulate the subcellular localization and the enzymatic activity of members of the Src family of kinases ." ], "offsets": [ [ 0, 169 ] ] } ]
[ { "id": "split_0_train_45815_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 30, 33 ] ], "normalized": [] }, { "id": "split_0_train_45816_entity", "type": "progene_text", "text": [ "Src" ], "offsets": [ [ 38, 41 ] ], "normalized": [] }, { "id": "split_0_train_45817_entity", "type": "progene_text", "text": [ "kinases" ], "offsets": [ [ 42, 49 ] ], "normalized": [] }, { "id": "split_0_train_45818_entity", "type": "progene_text", "text": [ "Src family of kinases" ], "offsets": [ [ 146, 167 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28280
split_0_train_28280
[ { "id": "split_0_train_28280_passage", "type": "progene_text", "text": [ "We show that simultaneous overexpression of FAK and pp60(c-src ) or p59 ( fyn ) results in the enhancement of the tyrosine phosphorylation of a limited number of cellular substrates , including paxillin ." ], "offsets": [ [ 0, 204 ] ] } ]
[ { "id": "split_0_train_45819_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 44, 47 ] ], "normalized": [] }, { "id": "split_0_train_45820_entity", "type": "progene_text", "text": [ "pp60(c-src )" ], "offsets": [ [ 52, 64 ] ], "normalized": [] }, { "id": "split_0_train_45821_entity", "type": "progene_text", "text": [ "p59 ( fyn )" ], "offsets": [ [ 68, 79 ] ], "normalized": [] }, { "id": "split_0_train_45822_entity", "type": "progene_text", "text": [ "paxillin" ], "offsets": [ [ 194, 202 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28281
split_0_train_28281
[ { "id": "split_0_train_28281_passage", "type": "progene_text", "text": [ "Under these conditions , tyrosine phosphorylation of paxillin is largely cell adhesion dependent ." ], "offsets": [ [ 0, 98 ] ] } ]
[ { "id": "split_0_train_45823_entity", "type": "progene_text", "text": [ "paxillin" ], "offsets": [ [ 53, 61 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28282
split_0_train_28282
[ { "id": "split_0_train_28282_passage", "type": "progene_text", "text": [ "FAK mutants defective for Src binding or focal adhesion targeting fail to cooperate with pp60(c-src ) or p59 ( fyn ) to induce paxillin phosphorylation , whereas catalytically defective FAK mutants can direct paxillin phosphorylation ." ], "offsets": [ [ 0, 235 ] ] } ]
[ { "id": "split_0_train_45824_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 0, 3 ] ], "normalized": [] }, { "id": "split_0_train_45825_entity", "type": "progene_text", "text": [ "Src" ], "offsets": [ [ 26, 29 ] ], "normalized": [] }, { "id": "split_0_train_45826_entity", "type": "progene_text", "text": [ "pp60(c-src )" ], "offsets": [ [ 89, 101 ] ], "normalized": [] }, { "id": "split_0_train_45827_entity", "type": "progene_text", "text": [ "p59 ( fyn )" ], "offsets": [ [ 105, 116 ] ], "normalized": [] }, { "id": "split_0_train_45828_entity", "type": "progene_text", "text": [ "paxillin" ], "offsets": [ [ 127, 135 ] ], "normalized": [] }, { "id": "split_0_train_45829_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 186, 189 ] ], "normalized": [] }, { "id": "split_0_train_45830_entity", "type": "progene_text", "text": [ "paxillin" ], "offsets": [ [ 209, 217 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28283
split_0_train_28283
[ { "id": "split_0_train_28283_passage", "type": "progene_text", "text": [ "The negative regulatory site of pp60(c-src ) is hypophosphorylated when in complex with FAK , and coexpression with FAK leads to a redistribution of pp60(c-src ) from a diffuse cellular location to focal adhesions ." ], "offsets": [ [ 0, 215 ] ] } ]
[ { "id": "split_0_train_45831_entity", "type": "progene_text", "text": [ "pp60(c-src" ], "offsets": [ [ 32, 42 ] ], "normalized": [] }, { "id": "split_0_train_45832_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 88, 91 ] ], "normalized": [] }, { "id": "split_0_train_45833_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 116, 119 ] ], "normalized": [] }, { "id": "split_0_train_45834_entity", "type": "progene_text", "text": [ "pp60(c-src )" ], "offsets": [ [ 149, 161 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28284
split_0_train_28284
[ { "id": "split_0_train_28284_passage", "type": "progene_text", "text": [ "A FAK mutant defective for Src binding does not effectively induce the translocation of pp60(c-src ) to focal adhesions ." ], "offsets": [ [ 0, 121 ] ] } ]
[ { "id": "split_0_train_45835_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 2, 5 ] ], "normalized": [] }, { "id": "split_0_train_45836_entity", "type": "progene_text", "text": [ "Src" ], "offsets": [ [ 27, 30 ] ], "normalized": [] }, { "id": "split_0_train_45837_entity", "type": "progene_text", "text": [ "pp60(c-src )" ], "offsets": [ [ 88, 100 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28285
split_0_train_28285
[ { "id": "split_0_train_28285_passage", "type": "progene_text", "text": [ "These results suggest that association with FAK can alter the localization of Src kinases and that FAK functions to direct phosphorylation of cellular substrates by recruitment of Src kinases ." ], "offsets": [ [ 0, 193 ] ] } ]
[ { "id": "split_0_train_45838_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 44, 47 ] ], "normalized": [] }, { "id": "split_0_train_45839_entity", "type": "progene_text", "text": [ "Src" ], "offsets": [ [ 78, 81 ] ], "normalized": [] }, { "id": "split_0_train_45840_entity", "type": "progene_text", "text": [ "kinases" ], "offsets": [ [ 82, 89 ] ], "normalized": [] }, { "id": "split_0_train_45841_entity", "type": "progene_text", "text": [ "FAK" ], "offsets": [ [ 99, 102 ] ], "normalized": [] }, { "id": "split_0_train_45842_entity", "type": "progene_text", "text": [ "Src" ], "offsets": [ [ 180, 183 ] ], "normalized": [] }, { "id": "split_0_train_45843_entity", "type": "progene_text", "text": [ "kinases" ], "offsets": [ [ 184, 191 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28286
split_0_train_28286
[ { "id": "split_0_train_28286_passage", "type": "progene_text", "text": [ "The long - term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide ." ], "offsets": [ [ 0, 99 ] ] } ]
[]
[]
[]
[]
split_0_train_28287
split_0_train_28287
[ { "id": "split_0_train_28287_passage", "type": "progene_text", "text": [ "The long - term safety , tolerability , and antihypertensive effects of irbesartan / hydrochlorothiazide ( HCTZ ) were assessed in hypertensive patients ( seated diastolic blood pressure [ SeDBP ] 95-110 mm Hg ) ." ], "offsets": [ [ 0, 213 ] ] } ]
[]
[]
[]
[]
split_0_train_28288
split_0_train_28288
[ { "id": "split_0_train_28288_passage", "type": "progene_text", "text": [ "Patients ( n = 1098 ) completing two randomised , double - blind trials of irbesartan alone , HCTZ alone , irbesartan / HCTZ combinations , or placebo , took 1 year of open - label therapy starting with irbesartan 75 mg / HCTZ 12.5 mg once daily ." ], "offsets": [ [ 0, 247 ] ] } ]
[]
[]
[]
[]
split_0_train_28289
split_0_train_28289
[ { "id": "split_0_train_28289_passage", "type": "progene_text", "text": [ "If target blood pressure ( BP ) ( < 140 / < 90 mm Hg ) was not achieved , the dose was titrated sequentially at 2 - to 4 - week intervals to irbesartan 150 mg / HCTZ 12 ." ], "offsets": [ [ 0, 170 ] ] } ]
[]
[]
[]
[]
split_0_train_28290
split_0_train_28290
[ { "id": "split_0_train_28290_passage", "type": "progene_text", "text": [ "5 mg , then to irbesartan 300 mg / HCTZ 25 mg ." ], "offsets": [ [ 0, 47 ] ] } ]
[]
[]
[]
[]
split_0_train_28291
split_0_train_28291
[ { "id": "split_0_train_28291_passage", "type": "progene_text", "text": [ "If necessary , adjunctive therapies were added ." ], "offsets": [ [ 0, 48 ] ] } ]
[]
[]
[]
[]
split_0_train_28292
split_0_train_28292
[ { "id": "split_0_train_28292_passage", "type": "progene_text", "text": [ "Mean changes in trough seated systolic BP / SeDBP at months 2 , 6 , and 12 were - 19.1 / - 14.2 mm Hg ( n = 941 ) , - 20.7 / - 15.7 mm Hg ( n = 948 ) , and - 20.6 / - 15.6 mm Hg ( n = 898 ) , respectively ." ], "offsets": [ [ 0, 206 ] ] } ]
[]
[]
[]
[]
split_0_train_28293
split_0_train_28293
[ { "id": "split_0_train_28293_passage", "type": "progene_text", "text": [ "From months 2 to 12 , normalisation rates ( trough SeDBP < 90 mm Hg ) ranged from 75 - 85 % and total responder rates ( normalised or > / = 10 mm Hg trough SeDBP reduction ) ranged from 81 - 91 % , while target BP was achieved in 65 - 75 % of patients ." ], "offsets": [ [ 0, 253 ] ] } ]
[]
[]
[]
[]
split_0_train_28294
split_0_train_28294
[ { "id": "split_0_train_28294_passage", "type": "progene_text", "text": [ "At all time - points , most patients ( > / = 87 % ) were receiving irbesartan / HCTZ alone ." ], "offsets": [ [ 0, 92 ] ] } ]
[]
[]
[]
[]
split_0_train_28295
split_0_train_28295
[ { "id": "split_0_train_28295_passage", "type": "progene_text", "text": [ "Eighty - two patients ( 7.5 % ) discontinued the study due to adverse events , with half of these events considered unrelated to study medication ." ], "offsets": [ [ 0, 147 ] ] } ]
[]
[]
[]
[]
split_0_train_28296
split_0_train_28296
[ { "id": "split_0_train_28296_passage", "type": "progene_text", "text": [ "There were no reports of serious adverse events related to study medication ." ], "offsets": [ [ 0, 77 ] ] } ]
[]
[]
[]
[]
split_0_train_28297
split_0_train_28297
[ { "id": "split_0_train_28297_passage", "type": "progene_text", "text": [ "Long - term therapy with irbesartan / HCTZ is safe , well tolerated , and maintains normalised BP in > 80 % of patients ." ], "offsets": [ [ 0, 121 ] ] } ]
[]
[]
[]
[]
split_0_train_28298
split_0_train_28298
[ { "id": "split_0_train_28298_passage", "type": "progene_text", "text": [ "[ Thyroid function in elderly with neoplasms ]" ], "offsets": [ [ 0, 46 ] ] } ]
[]
[]
[]
[]
split_0_train_28299
split_0_train_28299
[ { "id": "split_0_train_28299_passage", "type": "progene_text", "text": [ "BACKGROUND :" ], "offsets": [ [ 0, 12 ] ] } ]
[]
[]
[]
[]